<VariationArchive VariationID="220868" VariationName="NM_153240.5(NPHP3):c.2694-2_2694-1del" VariationType="Deletion" Accession="VCV000220868" Version="50" RecordType="classified" NumberOfSubmissions="24" NumberOfSubmitters="22" DateLastUpdated="2024-07-29" DateCreated="2016-10-22" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="221366" VariationID="220868">
      <GeneList>
        <Gene Symbol="NPHP3" FullName="nephrocystin 3" GeneID="27031" HGNC_ID="HGNC:7907" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132680609" stop="132722409" display_start="132680609" display_stop="132722409" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132399452" stop="132441302" display_start="132399452" display_stop="132441302" Strand="-" />
          </Location>
          <OMIM>608002</OMIM>
        </Gene>
        <Gene Symbol="NPHP3-ACAD11" FullName="NPHP3-ACAD11 readthrough (NMD candidate)" GeneID="100532724" HGNC_ID="HGNC:48351" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132558138" stop="132722459" display_start="132558138" display_stop="132722459" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_153240.5(NPHP3):c.2694-2_2694-1del</Name>
      <CanonicalSPDI>NC_000003.12:132689263:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132689264" stop="132689265" display_start="132689264" display_stop="132689265" variantLength="2" positionVCF="132689263" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132408108" stop="132408109" display_start="132408108" display_stop="132408109" variantLength="2" positionVCF="132408107" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>splice site</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.132408108_132408109del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.132408108_132408109del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.132689264_132689265del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.132689264_132689265del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008130.2" sequenceAccession="NG_008130" sequenceVersion="2" change="g.38168_38169del">
            <Expression>NG_008130.2:g.38168_38169del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153240.5" sequenceAccession="NM_153240" sequenceVersion="5" change="c.2694-2_2694-1del" MANESelect="true">
            <Expression>NM_153240.5:c.2694-2_2694-1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153240.4" sequenceAccession="NM_153240" sequenceVersion="4" change="c.2694-2_2694-1del">
            <Expression>NM_153240.4:c.2694-2_2694-1del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA349747" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608002.0004" DB="OMIM" />
        <XRef Type="rs" ID="751527253" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00024" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        <AlleleFrequency Value="0.00026" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00026" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00027" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00036" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00047" Source="1000 Genomes Project 30x" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_153240.5(NPHP3):c.2694-2_2694-1del AND Renal-hepatic-pancreatic dysplasia 1" Accession="RCV000055628" Version="11">
        <ClassifiedConditionList TraitSetID="678">
          <ClassifiedCondition DB="MedGen" ID="C3715199">Renal-hepatic-pancreatic dysplasia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.2694-2_2694-1del AND NPHP3-related Meckel-like syndrome" Accession="RCV000002753" Version="16">
        <ClassifiedConditionList TraitSetID="677">
          <ClassifiedCondition DB="MedGen" ID="C2673885">NPHP3-related Meckel-like syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2019-08-12" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.2694-2_2694-1del AND Nephronophthisis" Accession="RCV000205615" Version="13">
        <ClassifiedConditionList TraitSetID="16865">
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.2694-2_2694-1del AND Polycystic kidney disease" Accession="RCV000256425" Version="6">
        <ClassifiedConditionList TraitSetID="8312">
          <ClassifiedCondition DB="MedGen" ID="C0022680">Polycystic kidney disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.2694-2_2694-1del AND not provided" Accession="RCV000355185" Version="29">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-06-01" SubmissionCount="9">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.2694-2_2694-1del AND Nephronophthisis 3" Accession="RCV000593585" Version="11">
        <ClassifiedConditionList TraitSetID="676">
          <ClassifiedCondition DB="MedGen" ID="C1858392">Nephronophthisis 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-29" SubmissionCount="6">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.2694-2_2694-1del AND multiple conditions" Accession="RCV002500658" Version="3">
        <ClassifiedConditionList TraitSetID="10177">
          <ClassifiedCondition DB="MedGen" ID="C2673885">NPHP3-related Meckel-like syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1858392">Nephronophthisis 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3715199">Renal-hepatic-pancreatic dysplasia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.2694-2_2694-1del AND NPHP3-related disorder" Accession="RCV004530240" Version="1">
        <ClassifiedConditionList TraitSetID="87291">
          <ClassifiedCondition>NPHP3-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-29" NumberOfSubmissions="24" NumberOfSubmitters="22" DateCreated="2016-10-22" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general" Abbrev="ACMG, 2015">
          <ID Source="PubMed">25741868</ID>
          <ID Source="pmc">4544753</ID>
          <ID Source="DOI">10.1038/gim.2015.30</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18371931</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20007846</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23559409</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26673778</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27894351</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28921755</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28973083</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30002499</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31980526</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32055034</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32552793</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33532864</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=NPHP3</URL>
        </Citation>
        <DescriptionHistory Dated="2021-04-01">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="87291" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="68860" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NPHP3-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NPHP3-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NPHP3-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="678" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3602" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Renal-hepatic-pancreatic dysplasia 1</ElementValue>
                <XRef ID="MONDO:0008833" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RHPD1</ElementValue>
                <XRef Type="MIM" ID="208540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18431" />
                <XRef ID="18431" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3715199" DB="MedGen" />
              <XRef ID="MONDO:0008833" DB="MONDO" />
              <XRef Type="MIM" ID="208540" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="676" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5620" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Adolescent nephronophthisis</ElementValue>
                <XRef ID="Adolescent+nephronophthisis/7636" DB="Genetic Alliance" />
                <XRef ID="444749006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 3</ElementValue>
                <XRef ID="72010" DB="GeneTests" />
                <XRef ID="MONDO:0011456" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NPH3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18179" />
                <XRef ID="18179" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C1858392" DB="MedGen" />
              <XRef ID="MONDO:0011456" DB="MONDO" />
              <XRef Type="MIM" ID="604387" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="677" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9804" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dandy-Walker cyst with renal-hepatic-pancreatic dysplasia</ElementValue>
                <XRef ID="Dandy-Walker+Cyst+with+Renal-Hepatic-Pancreatic+Dysplasia/2103" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">NPHP3-related Meckel-like syndrome</ElementValue>
                <XRef ID="MONDO:0009966" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GOLDSTON SYNDROME</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Meckel syndrome type 7</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MKS7</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NPHP3</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4665" />
                <XRef ID="4665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3032" DB="Orphanet" />
              <XRef ID="C2673885" DB="MedGen" />
              <XRef ID="MONDO:0009966" DB="MONDO" />
              <XRef Type="MIM" ID="267010" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3602" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Renal-hepatic-pancreatic dysplasia 1</ElementValue>
                <XRef ID="MONDO:0008833" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RHPD1</ElementValue>
                <XRef Type="MIM" ID="208540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18431" />
                <XRef ID="18431" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3715199" DB="MedGen" />
              <XRef ID="MONDO:0008833" DB="MONDO" />
              <XRef Type="MIM" ID="208540" DB="OMIM" />
            </Trait>
            <Trait ID="9804" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dandy-Walker cyst with renal-hepatic-pancreatic dysplasia</ElementValue>
                <XRef ID="Dandy-Walker+Cyst+with+Renal-Hepatic-Pancreatic+Dysplasia/2103" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">NPHP3-related Meckel-like syndrome</ElementValue>
                <XRef ID="MONDO:0009966" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GOLDSTON SYNDROME</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Meckel syndrome type 7</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MKS7</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NPHP3</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4665" />
                <XRef ID="4665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3032" DB="Orphanet" />
              <XRef ID="C2673885" DB="MedGen" />
              <XRef ID="MONDO:0009966" DB="MONDO" />
              <XRef Type="MIM" ID="267010" DB="OMIM" />
            </Trait>
            <Trait ID="5620" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Adolescent nephronophthisis</ElementValue>
                <XRef ID="Adolescent+nephronophthisis/7636" DB="Genetic Alliance" />
                <XRef ID="444749006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 3</ElementValue>
                <XRef ID="72010" DB="GeneTests" />
                <XRef ID="MONDO:0011456" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NPH3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18179" />
                <XRef ID="18179" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C1858392" DB="MedGen" />
              <XRef ID="MONDO:0011456" DB="MONDO" />
              <XRef Type="MIM" ID="604387" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8312" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="17137" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney dysplasia</ElementValue>
                <XRef ID="HP:0000113" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Polycystic kidney disease</ElementValue>
                <XRef ID="MONDO:0020642" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS173900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kidney, Polycystic</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7419" />
                <XRef ID="7419" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0022680" DB="MedGen" />
              <XRef ID="D007690" DB="MeSH" />
              <XRef ID="MONDO:0020642" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS173900" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000113" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004716" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004739" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004740" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008645" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008673" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008699" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="619939" SubmissionDate="2016-10-02" DateLastUpdated="2016-10-22" DateCreated="2016-10-22">
        <ClinVarSubmissionID localKey="NM_153240.4:c.2694-2_2694-1delAG|Polycystic kidney disease" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000322802" DateUpdated="2016-10-22" DateCreated="2016-10-22" Type="SCV" Version="1" SubmitterName="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" OrgID="500184" OrganizationCategory="laboratory" OrgAbbreviation="DGU-KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Lethal polycystic kidney disease with positive family history</ElementValue>
                </Name>
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Lethal polycystic kidney disease</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.4:c.2694-2_2694-1delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Polycystic kidney disease</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1379224" SubmissionDate="2018-09-19" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="60234_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000706826" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000706827" DateChanged="2019-08-06" Version="1">
            <Comment Type="MergeComment">SCV000706827 was merged into SCV000706826 to remove duplication.</Comment>
          </Replaced>
          <Replaced Accession="SCV000706825" DateChanged="2019-08-06" Version="1">
            <Comment Type="MergeComment">SCV000706825 was merged into SCV000706826 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2017-03-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="-" referenceAllele="CT" start="132408108" stop="132408109" variantLength="2" />
            <GeneLocation>NM_153240.4:IVS19</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD082161" />
            <XRef DB="dbSNP" ID="751527253" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=NPHP3</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="22911" SubmissionDate="2018-01-19" DateLastUpdated="2018-12-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608002.0004_MECKEL SYNDROME, TYPE 7" title="NPHP3, IVS19AS, 2-BP DEL_MECKEL SYNDROME, TYPE 7" />
        <ClinVarAccession Accession="SCV000022911" DateUpdated="2018-12-15" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Meckel Syndrome, Type 7</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bergmann et al. (2008) reported 2 female fetuses (family 806), born of consanguineous Turkish parents, with enlarged renal-hepatic-pancreatic dysplasia; one of the fetuses also had Dandy-Walker cyst. The features were consistent with Meckel syndrome-7 (MKS7; 267010). In both fetuses, Bergmann et al. (2008) identified a homozygous deletion in the intron 19 splice acceptor site of the NPHP3 gene (c.2694-1_2 del), resulting in premature protein truncation. One pregnancy was terminated at 23 weeks, and one fetus died in the perinatal period. Both had multicystic dysplastic kidneys and hepatic ductal plate malformation. One had aortic stenosis.</Attribute>
              <Citation>
                <ID Source="PubMed">18371931</ID>
              </Citation>
              <XRef DB="OMIM" ID="267010" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Renal-Hepatic-Pancreatic Dysplasia 1</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Fiskerstrand et al. (2010) reported 2 Norwegian sibs, born to remotely consanguineous parents, with lethal renal-hepatic-pancreatic dysplasia-1 (RHPD1; 208540) who were homozygous for an AG deletion in intron 19 of the NPHP3 gene. The first child had intrauterine growth retardation, Potter facies with hypertelorism, beak-like nose, short neck, and short sternum, and died of respiratory insufficiency 1 day after birth. The pregnancy was complicated by oligohydramnios. The lungs and kidneys were hypoplastic, and the kidneys contained multiple small cysts and were dysplastic. The pancreas was enlarged, fibrotic, and showed irregular ducts and atrophy of acini. There was portal fibrosis and paucity of bile ducts in the liver. The brain was normal. The second pregnancy resulted in elective termination at 16 weeks because of multiple abnormalities in the fetus. The fetus had dysmorphic features consistent with Potter facies and flexion contractures of multiple joints. There was complete situs inversus of the thoracic and abdominal organs. Microscopic studies showed renal dysplasia, hepatic ductal plate malformation, and dysplasia of the pancreas with dilated ductal structures with scarce lobular differentiation. Although the brain was grossly normal, there was evidence of polymicrogyria. Fiskerstrand et al. (2010) noted the phenotypic similarities to the Turkish patients reported by Bergmann et al. (2008).</Attribute>
              <Citation>
                <ID Source="PubMed">20007846</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18371931</ID>
              </Citation>
              <XRef DB="OMIM" ID="208540" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <Name>NPHP3, IVS19AS, 2-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS19AS, 2-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608002.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MECKEL SYNDROME, TYPE 7</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="145118" SubmissionDate="2018-01-19" DateLastUpdated="2018-12-15" DateCreated="2013-09-20">
        <ClinVarSubmissionID localKey="608002.0004_RENAL-HEPATIC-PANCREATIC DYSPLASIA 1" title="NPHP3, IVS19AS, 2-BP DEL_RENAL-HEPATIC-PANCREATIC DYSPLASIA 1" />
        <ClinVarAccession Accession="SCV000083853" DateUpdated="2018-12-15" DateCreated="2013-09-20" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Meckel Syndrome, Type 7</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bergmann et al. (2008) reported 2 female fetuses (family 806), born of consanguineous Turkish parents, with enlarged renal-hepatic-pancreatic dysplasia; one of the fetuses also had Dandy-Walker cyst. The features were consistent with Meckel syndrome-7 (MKS7; 267010). In both fetuses, Bergmann et al. (2008) identified a homozygous deletion in the intron 19 splice acceptor site of the NPHP3 gene (c.2694-1_2 del), resulting in premature protein truncation. One pregnancy was terminated at 23 weeks, and one fetus died in the perinatal period. Both had multicystic dysplastic kidneys and hepatic ductal plate malformation. One had aortic stenosis.</Attribute>
              <Citation>
                <ID Source="PubMed">18371931</ID>
              </Citation>
              <XRef DB="OMIM" ID="267010" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Renal-Hepatic-Pancreatic Dysplasia 1</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Fiskerstrand et al. (2010) reported 2 Norwegian sibs, born to remotely consanguineous parents, with lethal renal-hepatic-pancreatic dysplasia-1 (RHPD1; 208540) who were homozygous for an AG deletion in intron 19 of the NPHP3 gene. The first child had intrauterine growth retardation, Potter facies with hypertelorism, beak-like nose, short neck, and short sternum, and died of respiratory insufficiency 1 day after birth. The pregnancy was complicated by oligohydramnios. The lungs and kidneys were hypoplastic, and the kidneys contained multiple small cysts and were dysplastic. The pancreas was enlarged, fibrotic, and showed irregular ducts and atrophy of acini. There was portal fibrosis and paucity of bile ducts in the liver. The brain was normal. The second pregnancy resulted in elective termination at 16 weeks because of multiple abnormalities in the fetus. The fetus had dysmorphic features consistent with Potter facies and flexion contractures of multiple joints. There was complete situs inversus of the thoracic and abdominal organs. Microscopic studies showed renal dysplasia, hepatic ductal plate malformation, and dysplasia of the pancreas with dilated ductal structures with scarce lobular differentiation. Although the brain was grossly normal, there was evidence of polymicrogyria. Fiskerstrand et al. (2010) noted the phenotypic similarities to the Turkish patients reported by Bergmann et al. (2008).</Attribute>
              <Citation>
                <ID Source="PubMed">20007846</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18371931</ID>
              </Citation>
              <XRef DB="OMIM" ID="208540" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <Name>NPHP3, IVS19AS, 2-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS19AS, 2-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608002.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">RENAL-HEPATIC-PANCREATIC DYSPLASIA 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="642706" SubmissionDate="2022-06-01" DateLastUpdated="2023-03-04" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:229564" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329431" DateUpdated="2023-03-04" DateCreated="2016-12-06" Type="SCV" Version="8" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate this variant leads to loss of splice acceptor resulting in skipping of exon 20 (Molinari et al., 2018); This variant is associated with the following publications: (PMID: 27894351, 28973083, 30002499, 34426522, 32055034, 31980526, 32552793, 32901917, 20007846, 18371931, 33726816, 27535533)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="3" alternateAllele="-" referenceAllele="CT" start="132408108" stop="132408109" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:45093</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_109_20220601054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_71_20211117054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1360285" SubmissionDate="2023-05-03" DateLastUpdated="2023-05-06" DateCreated="2018-01-23">
        <ClinVarSubmissionID localKey="3e7f3772-133a-4d52-8e92-e3a7c40e33a3" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000693903" DateUpdated="2023-05-06" DateCreated="2018-01-23" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous c.2694-2_2694-1del variant in NPHP3 was identified by our study in one individual with renal-hepatic-pancreatic dysplasia 1. Trio exome analysis showed this variant to be in trans with a likely pathogenic variant (ClinVar Variation ID: 635041). The c.2694-2_2694-1del variant in NPHP3 has been previously reported in 22 unrelated individuals with NPHP3-related disease (PMID: 33532864, PMID: 28973083, PMID: 32055034, PMID: 32552793, PMID: 32901917, PMID: 27894351, PMID: 33726816, PMID: 23559409, PMID: 26673778, PMID: 30002499, PMID: 33323469), but has been identified in 0.04% (14/30612) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs963574014). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. Of these 22 previously reported unrelated individuals (PMID: 33532864, PMID: 28973083, PMID: 32055034, PMID: 32552793, PMID: 32901917, PMID: 27894351, PMID: 33726816, PMID: 23559409, PMID: 26673778, PMID: 30002499, PMID: 33323469), 12 were homozygotes (PMID: 32055034, PMID: 32552793, PMID: 27894351, PMID: 18371931, PMID: 20007846) and 4 were compound heterozygotes who carried pathogenic or likely pathogenic variants in trans (PMID: 33532864, ClinVar Variation ID: 659899; PMID: 28973083, ClinVar Variation ID: 988261; PMID: 23559409, ClinVar Variation ID: 96511, ClinVar Variation ID: 693989 ; PMID: 30002499, ClinVar Variation ID: 262696; PMID: 33323469, ClinVar Variation ID: 1454640), which increases the likelihood that the c.2694-2_2694-1del variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 220868) and has been interpreted as pathogenic by multiple submitters. RT-PCR analysis performed on affected tissue shows evidence of altered splicing of exon 20 (PMID: 32552793, PMID: 30002499, PMID: 20007846). A different nucleotide change that also results in a splice acceptor variant at the same site, c.2694-2A&gt;T (ClinVar Variation ID: 1524627), has been previously reported likely pathogenic, and the variant being assessed here, c.2694-2_2694-1del, is predicted by SpliceAI to have a similar effect on splicing. This variant is located in the 3' splice region. Computational tools do suggest an impact to splicing. However, this information is not predictive enough to determine pathogenicity. There is an in-frame cryptic splice site 21 bases from the intron-exon boundary, providing evidence that this variant may delete 7 amino acids instead of causing loss of function. However, this information is not predictive enough to determine pathogenicity. Loss of function of the NPHP3 gene is an established disease mechanism in autosomal recessive renal-hepatic-pancreatic dysplasia 1. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive renal-hepatic-pancreatic dysplasia 1. ACMG/AMP Criteria applied: PVS1_Moderate, PS1_Supporting, PS3_Moderate, PM3_VeryStrong (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_153240.5(NPHP3):c.2694-2_2694-1del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.12:g.132689264_132689265del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008833" />
          </Trait>
        </TraitSet>
        <StudyName>Broad Institute Center for Mendelian Genomics (CMG)</StudyName>
        <SubmissionNameList>
          <SubmissionName>Broad Institute Center for Mendelian Genomics (CMG)</SubmissionName>
          <SubmissionName>SUB13232620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="486756" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2016-02-02">
        <ClinVarSubmissionID localKey="78208|MedGen:C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000261757" DateUpdated="2024-02-20" DateCreated="2016-02-02" Type="SCV" Version="11" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18371931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20007846</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26673778</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20007846</ID>
          </Citation>
          <Comment>This sequence change affects a splice site in intron 19 of the NPHP3 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs751527253, gnomAD 0.05%). Disruption of this splice site has been observed in individual(s) with Meckel-Gruber-like syndrome and/or nephronophthisis-related ciliopathy (PMID: 18371931, 20007846, 23559409, 26673778). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 220868). Studies have shown that disruption of this splice site results in activation of a cryptic splice site and introduces a premature termination codon (PMID: 20007846). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.132408108_132408109del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1578112" SubmissionDate="2018-09-24" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GHARVar098|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000809211" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="1" SubmitterName="Gharavi Laboratory, Columbia University" OrgID="506730" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CCT" start="132408107" stop="132408109" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4556013</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1807858" SubmissionDate="2018-09-26" DateLastUpdated="2019-06-24" DateCreated="2019-06-24">
        <ClinVarSubmissionID localKey=":Chr.3_132408107_132408109_CCT_C|OMIM:604387" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924491" DateUpdated="2019-06-24" DateCreated="2019-06-24" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous c.2694-2_2694-1delAG variant was identified by our study in the compound heterozygous state, with a pathogenic variant, in one individual with nephronophthisis. This variant is pathogenic based off of multiple reports in ClinVar and the literature.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>WES</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Congenital syndromic ciliopathy</ElementValue>
                </Name>
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Enlarged-cystic kidneys</ElementValue>
                </Name>
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Congenital heart desease</ElementValue>
                </Name>
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Situs inversus</ElementValue>
                </Name>
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Perinatal death (respiratory distress)</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CCT" start="132408107" stop="132408109" variantLength="3" />
          </Location>
          <OtherNameList>
            <Name>c.2694-2_2694-1delAG</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4567551</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2813790" SubmissionDate="2020-07-10" DateLastUpdated="2021-01-17" DateCreated="2021-01-17">
        <ClinVarSubmissionID localKey="NM_153240.5:c.2694-2_2694-1del|OMIM:604387" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001425113" DateUpdated="2021-01-17" DateCreated="2021-01-17" Type="SCV" Version="1" SubmitterName="Molecular Biology Laboratory, Fundació Puigvert" OrgID="507661" OrganizationCategory="laboratory" OrgAbbreviation="Lab BM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">33532864</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.5:c.2694-2_2694-1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">33532864</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33532864</ID>
        </Citation>
        <StudyName>KidneyPanel_2020</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB7750420</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2697652" SubmissionDate="2020-11-24" DateLastUpdated="2020-12-12" DateCreated="2020-07-06">
        <ClinVarSubmissionID localKey="NM_153240.4:c.2694-2_2694-1delAG|OMIM:267010" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001369566" DateUpdated="2020-12-12" DateCreated="2020-07-06" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PS3,PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.4:c.2694-2_2694-1delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="267010" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3546884" SubmissionDate="2021-08-24" DateLastUpdated="2021-08-25" DateCreated="2021-08-25">
        <ClinVarSubmissionID localKey=":Chr.3_132408107_132408109_CCT_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001806968" DateUpdated="2021-08-25" DateCreated="2021-08-25" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, Amsterdam University Medical Center" OrgID="506453" OrganizationCategory="laboratory" OrgAbbreviation="VUMC GD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CCT" start="132408107" stop="132408109" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10240015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3430227" SubmissionDate="2021-09-02" DateLastUpdated="2021-09-08" DateCreated="2021-07-07">
        <ClinVarSubmissionID localKey=":Chr.3_132408107_132408109_CCT_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001742234" DateUpdated="2021-09-08" DateCreated="2021-07-07" Type="SCV" Version="3" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" OrgID="506382" OrganizationCategory="laboratory" OrgAbbreviation="DL-UMCG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CCT" start="132408107" stop="132408109" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <StudyDescription>VKGL Data-share Consensus</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB10172767</SubmissionName>
          <SubmissionName>SUB10306554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3855759" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-07" DateCreated="2021-10-07">
        <ClinVarSubmissionID localKey=":Chr.3_132408107_132408109_CCT_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001967526" DateUpdated="2021-10-07" DateCreated="2021-10-07" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CCT" start="132408107" stop="132408109" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3950667" SubmissionDate="2021-11-05" DateLastUpdated="2021-11-11" DateCreated="2021-11-11">
        <ClinVarSubmissionID localKey="3-132408107-CCT-C" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002012327" DateUpdated="2021-11-11" DateCreated="2021-11-11" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.0002759, PM2).The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000220868.16). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000092" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000097" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0012210" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001510" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001328" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003774" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.4:c.2694-2_2694-1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10606558</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3999863" SubmissionDate="2021-12-16" DateLastUpdated="2021-12-21" DateCreated="2021-12-21">
        <ClinVarSubmissionID localKey=":Chr.3_132408107_132408109_CCT_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002037362" DateUpdated="2021-12-21" DateCreated="2021-12-21" Type="SCV" Version="1" SubmitterName="Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+" OrgID="505925" OrganizationCategory="laboratory" OrgAbbreviation="Radboudumc_MUMC+" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CCT" start="132408107" stop="132408109" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10812646</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4894835" SubmissionDate="2022-04-22" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey=":Chr.3_132408107_CCT_C|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002501393" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="AiLife Diagnostics, AiLife Diagnostics" OrgID="507594" OrganizationCategory="laboratory" OrgAbbreviation="AiLife" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18371931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31980526</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32552793</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28973083</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27894351</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32055034</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CCT" start="132408107" stop="132408109" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350707</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5413790" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_153240_4_NPHP3_c_2694_2_2694_1delAG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002766885" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28921755</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30002499</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32055034</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Meckel syndrome 7 (MIM# 267010), nephronophthisis 3 (MIM# 604387) and renal-hepatic-pancreatic dysplasia 1 (MIM# 208540). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0210 - Splice site variant proven to affect splicing of the transcript with a known effect on protein sequence. RT-PCR done on whole blood RNA of an affected individual demonstrated exon 20 skipping, which is expected to result in a frameshift (PMID: 30002499). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD &lt;0.01 for a recessive condition (v2: 78 heterozygotes, 0 homozygotes). (SP) 0311 - An alternative nucleotide change at the same canonical splice site is present in gnomAD (v3: 1 heterozygote, 0 homozygotes). (SB) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in at least ten individuals described to have nephronophthisis, end stage renal disease or ciliopathy syndrome and consistently classified as pathogenic by diagnostic laboratories in ClinVar (PMID: 28921755, 30002499, 32055034). (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_13823</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.4:c.2694-2_2694-1delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5463627" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_153240.5:c.2694-2_2694-1del|OMIM:208540;267010;604387" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002810601" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.5:c.2694-2_2694-1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="208540" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="267010" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7574386" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="20300142197" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004047650" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The splice site c.2694-2_2694-1del variant has been reported to segregate with Meckel syndrome and embryonic lethality in families (Bergmann et. al., 2008). An experimental study has shown that this variant results in altered splicing, likely by usage of a cryptic splice site, resulting in a prematurely truncated protein (Fiskerstrand et. al., 2010). The c.2694-2_2694-1del variant is novel (not in any individuals) in 1000 Genomes and has allele frequency of 0.02759% in gnomAD database. This variant has been reported to the ClinVar database as Pathogenic/Likely Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (Baralle D, Baralle M., 2005), and loss-of-function variants in NPHP3 are known to be pathogenic (Halbritter et. al., 2013). For these reasons, this variant has been classified as Pathogenic. In the absence of another reportable variant, the molecular diagnosis is not confirmed. The same variant (c.2694-2_2694-1del) has been observed in her father.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0012758" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000733" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000486" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0025404" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001257" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001347" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0006466" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001138" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002059" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001305" />
              </Trait>
              <Comment>Patient was referred for genetic evaluation with her parents. Clinical symptoms: GDD - delayed developmental milestones, repetitive hand movements, squint, no visual fixation, spasticity, exaggerated DTR, bilateral ankle contractures Investigations: Eye investigation is suggestive of early optic neuropathy. MRI Brain is suggestive of severe cerebral atrophy and Dandy-walker malformation. Karyotype is normal - 46, XX.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.5:c.2694-2_2694-1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="267010" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7886022" SubmissionDate="2023-12-29" DateLastUpdated="2024-06-23" DateCreated="2024-06-23">
        <ClinVarSubmissionID localKey="NM_153240.5:c.2694-2_2694-1del|OMIM:604387" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004218469" DateUpdated="2024-06-23" DateCreated="2024-06-23" Type="SCV" Version="1" SubmitterName="Precision Medicine Center, Zhengzhou University" OrgID="507840" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18371931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
          <Comment>PVS1,PM2_p</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.5:c.2694-2_2694-1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14114128</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7696562" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="2196722|NPHP3-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004115080" DateUpdated="2024-03-16" DateCreated="2023-11-20" Type="SCV" Version="2" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The NPHP3 c.2694-2_2694-1delAG variant is predicted to result in a deletion affecting a canonical splice site. This variant has been reported in the homozygous and compound heterozygous states in multiple individuals with NPHP3 related disorders (Bergmann et al. 2008. PubMed ID: 18371931; Meng et al 2017. PubMed ID: 28973083; Shaheen et al 2016. PubMed ID: 27894351; Shamseldin et al. 2021. PubMed ID: 34645488). Expression assays reveal that this variant leads to skipping of exon 20 (Maddirevula et al. 2020. PubMed ID: 32552793). This variant is reported in 0.046% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.4:c.2694-2_2694-1delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NPHP3-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8988251" SubmissionDate="2024-03-29" DateLastUpdated="2024-04-06" DateCreated="2024-04-06">
        <ClinVarSubmissionID localKey="NM_153240.5:c.2694-2_2694-1del|OMIM:604387" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004807901" DateUpdated="2024-04-06" DateCreated="2024-04-06" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.5:c.2694-2_2694-1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14345719</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4980288" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-07-09">
        <ClinVarSubmissionID localKey="115816|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002544835" DateUpdated="2024-07-15" DateCreated="2022-07-09" Type="SCV" Version="13" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>NPHP3: PVS1, PS3:Supporting, PS4:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="C" referenceAllele="CCT" start="132408107" stop="132408109" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001510" MappingRef="HP">
        <MedGen CUI="C0456070" Name="Growth delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807858" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001347" MappingRef="HP">
        <MedGen CUI="C0151889" Name="Hyperreflexia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2697652" TraitType="Disease" MappingType="XRef" MappingValue="267010" MappingRef="OMIM">
        <MedGen CUI="C2673885" Name="NPHP3-related Meckel-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001305" MappingRef="HP">
        <MedGen CUI="C0010964" Name="Dandy-Walker syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1578112" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="145118" TraitType="Disease" MappingType="Name" MappingValue="RENAL-HEPATIC-PANCREATIC DYSPLASIA 1" MappingRef="Alternate">
        <MedGen CUI="C3715199" Name="Renal-hepatic-pancreatic dysplasia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3999863" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8988251" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463627" TraitType="Disease" MappingType="XRef" MappingValue="267010" MappingRef="OMIM">
        <MedGen CUI="C2673885" Name="NPHP3-related Meckel-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2813790" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3855759" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012210" MappingRef="HP">
        <MedGen CUI="C4551596" Name="Abnormal renal morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807858" TraitType="Finding" MappingType="Name" MappingValue="Congenital heart desease" MappingRef="Preferred">
        <MedGen CUI="None" Name="Congenital heart desease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="619939" TraitType="Finding" MappingType="Name" MappingValue="Lethal polycystic kidney disease" MappingRef="Preferred">
        <MedGen CUI="CN238732" Name="Lethal polycystic kidney disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3430227" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="486756" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4894835" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7696562" TraitType="Disease" MappingType="Name" MappingValue="NPHP3-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="NPHP3-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0025404" MappingRef="HP">
        <MedGen CUI="C4477094" Name="Abnormal visual fixation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000097" MappingRef="HP">
        <MedGen CUI="C0017668" Name="Focal segmental glomerulosclerosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463627" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5413790" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="642706" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Disease" MappingType="XRef" MappingValue="267010" MappingRef="OMIM">
        <MedGen CUI="C2673885" Name="NPHP3-related Meckel-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3546884" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="619939" TraitType="Finding" MappingType="Name" MappingValue="Lethal polycystic kidney disease with positive family history" MappingRef="Preferred">
        <MedGen CUI="CN238731" Name="Lethal polycystic kidney disease with positive family history" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807858" TraitType="Finding" MappingType="Name" MappingValue="Enlarged-cystic kidneys" MappingRef="Preferred">
        <MedGen CUI="None" Name="Enlarged-cystic kidneys" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0006466" MappingRef="HP">
        <MedGen CUI="C1837407" Name="Ankle flexion contracture" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004322" MappingRef="HP">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1360285" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008833" MappingRef="MONDO">
        <MedGen CUI="C3715199" Name="Renal-hepatic-pancreatic dysplasia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1379224" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807858" TraitType="Finding" MappingType="Name" MappingValue="Perinatal death (respiratory distress)" MappingRef="Preferred">
        <MedGen CUI="None" Name="Perinatal death (respiratory distress)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000486" MappingRef="HP">
        <MedGen CUI="C0038379" Name="Strabismus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012758" MappingRef="HP">
        <MedGen CUI="C4022738" Name="Neurodevelopmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000733" MappingRef="HP">
        <MedGen CUI="C0038271" Name="Motor stereotypies" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001328" MappingRef="HP">
        <MedGen CUI="C4025790" Name="Specific learning disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001257" MappingRef="HP">
        <MedGen CUI="C0026838" Name="Spasticity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807858" TraitType="Finding" MappingType="Name" MappingValue="Congenital syndromic ciliopathy" MappingRef="Preferred">
        <MedGen CUI="None" Name="Congenital syndromic ciliopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="619939" TraitType="Finding" MappingType="Name" MappingValue="Polycystic kidney disease" MappingRef="Preferred">
        <MedGen CUI="C0022680" Name="Polycystic kidney disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7886022" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002059" MappingRef="HP">
        <MedGen CUI="C0235946" Name="Cerebral atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="22911" TraitType="Disease" MappingType="Name" MappingValue="MECKEL SYNDROME, TYPE 7" MappingRef="Preferred">
        <MedGen CUI="C2673885" Name="NPHP3-related Meckel-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574386" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001138" MappingRef="HP">
        <MedGen CUI="C3887709" Name="Optic neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000092" MappingRef="HP">
        <MedGen CUI="C1858395" Name="Renal tubular atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463627" TraitType="Disease" MappingType="XRef" MappingValue="208540" MappingRef="OMIM">
        <MedGen CUI="C3715199" Name="Renal-hepatic-pancreatic dysplasia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807858" TraitType="Finding" MappingType="Name" MappingValue="Situs inversus" MappingRef="Preferred">
        <MedGen CUI="C4551493" Name="Situs inversus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950667" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003774" MappingRef="HP">
        <MedGen CUI="C2316810" Name="Stage 5 chronic kidney disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4980288" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001527512</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

